Scientific Sessions 2025  /  Inflammation and Atherosclerosis: Smoldering Threat or Therapeutic Target?  /  Debate: Seeing the Fire or Measuring the Smoke? The Battle for Superior Risk Stratification: Imaging Biomarkers
Logo

American Heart Association

  32
  0

Final ID:

Debate: Seeing the Fire or Measuring the Smoke? The Battle for Superior Risk Stratification: Imaging Biomarkers

  • Weber, Brittany  ( Brigham and Women's Hospital , Dedham , Massachusetts , United States )
  • Blankstein, Ron  ( BRIGHAM AND WOMENS HOSPITAL , Boston , Massachusetts , United States )
    • Author Disclosures:
    Brittany Weber: DO have relevant financial relationships ; Advisor:Novo Nordisk :Active (exists now) ; Advisor:BMS :Active (exists now) ; Consultant:Oruka :Past (completed) ; Advisor:Kiniksa :Past (completed) | Ron Blankstein: DO have relevant financial relationships ; Consultant:Heartflow:Active (exists now) ; Researcher:Nanox AI:Active (exists now) ; Researcher:Heartflow:Active (exists now) ; Researcher:Amgen:Active (exists now) ; Researcher:Novartis Inc:Active (exists now) ; Consultant:Siemens Inc:Past (completed) ; Consultant:Caristo:Active (exists now) ; Consultant:Nanox AI:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Inflammation and Atherosclerosis: Smoldering Threat or Therapeutic Target?

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Debate- Colchicine for ASCVD: A Game-Changer or a Niche Therapy? Colchicine – ready for prime time

Mehta Anurag, Blaha Michael, Budoff Matthew

Beyond Lipids: The Current and Future Landscape of Anti-Inflammatory Therapies for ASCVD

Ridker Paul, Ballantyne Christie

More abstracts from these authors:
Just Focus on your Diet!

Blankstein Ron

Strategies and experiences as an early career member funded with NIH and external grants

Weber Brittany

You have to be authorized to contact abstract author. Please, Login
Not Available